Innovative chemotherapy approach shows promise against lung cancer

Lung cancer is not the most common form of cancer, but it is by far the deadliest. Despite treatments such as surgery, radiation therapy and chemotherapy, only about a quarter of all people with the disease will live more than five years after diagnosis, and lung cancer kills more than 1.8 million people worldwide each year, according to the World Health Organization.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news